Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 13, Issue 9
|
pp. 12849–12864
The prognostic and immunological effects of ZBTB7C across cancers: friend or foe?
Back to article
Figure 1
(1 of 7)
−
100%
+
Figure 1.
The expression level of ZBTB7C in human cancers.
(
A
) Oncomine database. (
B
) TIMER database. (
C
) TCGA database (
*
P
< 0.05,
**
P
< 0.01,
***
P
< 0.001).